|
1
|
Adamson C, Kanu OO, Mehta AI, Di C, Lin N,
Mattox AK and Bigner DD: Glioblastoma multiforme: A review of where
we have been and where we are going. Expert Opin Investig Drugs.
18:1061–1083. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Tellingen O, Yetkin-Arik B, de Gooijer
MC, Wesseling P, Wurdinger T and de Vries HE: Overcoming the
blood-brain tumor barrier for effective glioblastoma treatment.
Drug Resist Updat. 19:1–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Furnari FB, Cloughesy TF, Cavenee WK and
Mischel PS: Heterogeneity of epidermal growth factor receptor
signalling networks in glioblastoma. Nat Rev Cancer. 15:302–310.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ricklefs F, Mineo M, Rooj AK, Nakano I,
Charest A, Weissleder R, Breakefield XO, Chiocca EA, Godlewski J
and Bronisz A: Extracellular vesicles from high-grade glioma
exchange diverse pro-oncogenic signals that maintain intratumoral
heterogeneity. Cancer Res. 76:2876–2881. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nikaki A, Piperi C and Papavassiliou AG:
Role of microRNAs in gliomagenesis: Targeting miRNAs in
glioblastoma multiforme therapy. Expert Opin Investig Drugs.
21:1475–1488. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shang Y, Zang A, Li J, Jia Y, Li X, Zhang
L, Huo R, Yang J, Feng J, Ge K, et al: MicroRNA-383 is a tumor
suppressor and potential prognostic biomarker in human non-small
cell lung caner. Biomed Pharmacother. 83:1175–1181. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo J, Wu Q, Peng X and Yu B: miR-509-5p
inhibits the proliferation and invasion of osteosarcoma by
targeting TRIB2. Biomed Res Int. 2019:25230322019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rashad NM, El-Shal AS, Shalaby SM and
Mohamed SY: Serum miRNA-27a and miRNA-18b as potential predictive
biomarkers of hepatitis C virus-associated hepatocellular
carcinoma. Mol Cell Biochem. 447:125–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wuchty S, Arjona D, Li A, Kotliarov Y,
Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC and Fine
HA: Prediction of associations between microRNAs and gene
expression in glioma biology. PLoS One. 6:e146812011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cui JG, Zhao Y, Sethi P, Li YY, Mahta A,
Culicchia F and Lukiw WJ: Micro-RNA-128 (miRNA-128) down-regulation
in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key
regulators of brain cell proliferation. J Neurooncol. 98:297–304.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Godlewski J, Bronisz A, Nowicki MO,
Chiocca EA and Lawler S: microRNA-451: A conditional switch
controlling glioma cell proliferation and migration. Cell Cycle.
9:2742–2748. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang
Y, Yue X, Pu P, Zhong Y and Kang C: miRNA-451 plays a role as tumor
suppressor in human glioma cells. Brain Res. 1359:14–21. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahir BK, Ozer H, Engelhard HH and Lakka
SS: MicroRNAs in glioblastoma pathogenesis and therapy: A
comprehensive review. Crit Rev Oncol Hematol. 120:22–33. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Helming L, Tomasello E, Kyriakides TR,
Martinez FO, Takai T, Gordon S and Vivier E: Essential role of
DAP12 signaling in macrophage programming into a fusion-competent
state. Sci Signal. 1:ra112008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Nicolay BN, Chick JM, Gao X, Geng
Y, Ren H, Gao H, Yang G, Williams JA, Suski JM, et al: The
metabolic function of cyclin D3-CDK6 kinase in cancer cell
survival. Nature. 546:426–430. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Diehl JA: Cyclin D3: To translate or not
to translate. Cell Cycle. 15:3018–3019. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang F, Xu C, Reece EA, Li X, Wu Y, Harman
C, Yu J, Dong D, Wang C, Yang P, et al: Protein kinase C-alpha
suppresses autophagy and induces neural tube defects via miR-129-2
in diabetic pregnancy. Nat Commun. 8:151822017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Alifieris C and Trafalis DT: Glioblastoma
multiforme: Pathogenesis and treatment. Pharmacol Ther. 152:63–82.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jansen M, Yip S and Louis DN: Molecular
pathology in adult gliomas: Diagnostic, prognostic, and predictive
markers. Lancet Neurol. 9:717–726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu KP, Zhang CL, Ma XL, Hu JP, Cai T and
Zhang L: Analyzing the interactions of mRNAs and ncRNAs to predict
competing endogenous RNA networks in osteosarcoma chemo-resistance.
Mol Ther. 27:518–530. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang R, Liu M, Liang H, Guo S, Guo X, Yuan
M, Lian H, Yan X, Zhang S, Chen X, et al: miR-138-5p contributes to
cell proliferation and invasion by targeting Survivin in bladder
cancer cells. Mol Cancer. 15:822016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao Y, Fan X, Li W, Ping W, Deng Y and Fu
X: miR-138-5p reverses gefitinib resistance in non-small cell lung
cancer cells via negatively regulating G protein-coupled receptor
124. Biochem Biophys Res Commun. 446:179–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z,
Liu R, Tang A, Li X, Liu F and Shen S: The tumor suppressor
miR-138-5p targets PD-L1 in colorectal cancer. Oncotarget.
7:45370–45384. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu C, Wang M, Li Z, Xiao J, Peng F, Guo X,
Deng Y, Jiang J and Sun C: MicroRNA-138-5p regulates pancreatic
cancer cell growth through targeting FOXC1. Cell Oncol (Dordr).
38:173–181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yeh M, Oh CS, Yoo JY, Kaur B and Lee TJ:
Pivotal role of microRNA-138 in human cancers. Am J Cancer Res.
9:1118–1126. 2019.PubMed/NCBI
|
|
33
|
Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu
S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, et al: miR-138
exerts anti-glioma efficacy by targeting immune checkpoints. Neuro
Oncol. 18:639–648. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ye Z, Fang B, Pan J, Zhang N, Huang J, Xie
C, Lou T and Cao Z: miR-138 suppresses the proliferation,
metastasis and autophagy of non-small cell lung cancer by targeting
Sirt1. Oncol Rep. 37:3244–3252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ren D, Liu F, Dong G, You M, Ji J, Huang
Y, Hou Y and Fan H: Activation of TLR7 increases CCND3 expression
via the downregulation of miR-15b in B cells of systemic lupus
erythematosus. Cell Mol Immunol. 13:764–775. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sankaran VG, Orkin SH and Walkley CR: Rb
intrinsically promotes erythropoiesis by coupling cell cycle exit
with mitochondrial biogenesis. Genes Dev. 22:463–475. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sherr CJ and Roberts JM: Living with or
without cyclins and cyclin-dependent kinases. Genes Dev.
18:2699–2711. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin J, Jinno S and Okayama H: Cdk6-cyclin
D3 complex evades inhibition by inhibitor proteins and uniquely
controls cell's proliferation competence. Oncogene. 20:2000–2009.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang GL, Shi X, Salisbury E, Sun Y,
Albrecht JH, Smith RG and Timchenko NA: Cyclin D3 maintains
growth-inhibitory activity of C/EBPalpha by stabilizing
C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes. Mol Cell Biol.
26:2570–2582. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song S, Wu S, Wang Y, Wang Z, Ye C, Song
R, Song D and Ruan Y: 17β-estradiol inhibits human umbilical
vascular endothelial cell senescence by regulating autophagy via
p53. Exp Gerontol. 114:57–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiang X, Huang J, Song S, Wang Y, Zeng Y,
Wu S and Ruan Y: 17β-estradiol inhibits H 2 O
2-induced senescence in HUVEC cells through upregulating
SIRT3 expression and promoting autophagy. Biogerontology.
21:549–557. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang J, Annala M, Ji P, Wang G, Zheng H,
Codgell D, Du X, Fang Z, Sun B, Nykter M, et al: Recurrent
LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell
motility in human osteosarcoma. J Hematol Oncol. 7:762014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shan YS, Hsu HP, Lai MD, Hung YH, Wang CY,
Yen MC and Chen YL: Cyclin D1 overexpression correlates with poor
tumor differentiation and prognosis in gastric cancer. Oncol Lett.
14:4517–4526. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim Y, Kim J, Jang SW and Ko J: The role
of sLZIP in cyclin D3-mediated negative regulation of androgen
receptor transactivation and its involvement in prostate cancer.
Oncogene. 34:226–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun Q, Shi R, Wang X, Li D, Wu H and Ren
B: Overexpression of ZIC5 promotes proliferation in non-small cell
lung cancer. Biochem Biophys Res Commun. 479:502–509. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 9:8522017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bao XY and Cao J: miRNA-138-5p protects
the early diabetic retinopathy by regulating NOVA1. Eur Rev Med
Pharmacol Sci. 23:7749–7756. 2019.PubMed/NCBI
|
|
49
|
Guo S, Ma B, Jiang X, Li X and Jia Y:
Astragalus polysaccharides inhibits tumorigenesis and lipid
metabolism through miR-138-5p/SIRT1/SREBP1 pathway in prostate
cancer. Front Pharmacol. 11:5982020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li D, He C, Wang J, Wang Y, Bu J, Kong X
and Sun D: MicroRNA-138 inhibits cell growth, invasion, and EMT of
non-small cell lung cancer via SOX4/p53 feedback loop. Oncol Res.
26:385–400. 2018. View Article : Google Scholar : PubMed/NCBI
|
